Skip to main content
. Author manuscript; available in PMC: 2014 May 26.
Published in final edited form as: Nat Genet. 2012 Jul 8;44(8):916–921. doi: 10.1038/ng.2348

Table 1.

Comparison of the clinical features observed in patients with TGFB2 mutations and patients with TGFBR2, FBN1, or SMAD3 mutations.

Feature Frequency, no. individuals/total (%)a
TGFB2 TGFBR2 FBN1 SMAD3
Cardiovascular:
 Aortic root aneurysm 14/19 (74) 54/69 (78) 178/226 (79) 28/39 (72)
 Aortic dissection 3/23 (13) 10/71 (14) 23/243 (10) 13/39 (33)
 Cerebrovascular disease 3/10 (30) 0 b 0 b 6/16 (38)
 Arterial tortuosity 3/5 (60) 5/25 (20) NA 8/16 (50)c
 Mitral valve prolapse 3/19 (16) 15/66 (21) 105/232 (45) 18/36 (50)d
Skeletal:
 Pectus deformity 7/16 (44) 31/69 (45) 144/243 (59) 12/33 (36)
 Arachnodoctyly 8/13 (62) 28/70 (41) 137/240 (57) 13/33 (39)
 Spondylolisthesis 1/7 (14) 5/47 (11) 15/223 (7) 10/26 (38)
 Scoliosis 4/15 (27) 21/68 (31) 122/240 (51) 22/36 (61)
 Flat feet 11/15 (73) 8/58 (14) 108/243 (44) 30/33 (91)
 Protrusio acetabularis 1/8 (12) 3/47 (6) 79/221 (36) 7/20 (35)
 Joint hyperflexibility 10/15 (67) 45/59 (76) 168/243 (69) 3/31 (10)
 High arched palate 9/15 (60) 32/67 (48) 151/243 (62) 15/28 (54)d
Cutaneous:
 Striae atrophicae 8/15 (53) 24/66 (36) 139/241 (58) 17/32 (53)
 Operated hernia 6/17 (35) 13/67(19) e 40/239 (17)e 17/40 (43)
Pulmonary:
 Pneumothorax 1/17 (6) 3/69 (4) 10/240 (4) NA
Dural ectasia 3/5 (60) 4/40 (10) 64/220 (29) NA
a

The frequency of clinical features associated with TGFBR2, FBN1 and SMAD3 are based on previous publications 11, 17, 22. Provided are the number of individuals with the feature/total number of individuals assessed for the particular feature (percentage);

b

based on medical history (imaging to screen for asymptomatic vascular disease not done);

c

number of patients with tortuosity of the cerebral arteries;

d

designated in publication as abnormal palate;

e

number of individuals with recurrent hernias;

NA- data not available.